P2Y12 Inhibitor Monotherapy Combined With Colchicine Following PCI in ACS Patients: The MACT Pilot Study

被引:0
|
作者
Lee, Seung-Yul [1 ]
机构
[1] CHA Bundang Med Ctr, Seongnam, South Korea
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
TCT-44
引用
收藏
页码:B18 / B18
页数:1
相关论文
共 50 条
  • [1] P2Y12 Inhibitor Monotherapy Combined With Colchicine Following PCI in ACS Patients The MACT Pilot Study
    Lee, Seung-Yul
    Jeong, Young-Hoon
    Yun, Kyeong Ho
    Cho, Jae Young
    Gorog, Diana A.
    Angiolillo, Dominick J.
    Kim, Jin Won
    Jang, Yangsoo
    JACC-CARDIOVASCULAR INTERVENTIONS, 2023, 16 (15) : 1845 - 1855
  • [2] Reversible P2Y12 inhibitor versus irreversible P2Y12 inhibitor in ACS patients undergoing PCI (the acute coronary syndrome israeli survey (ACSIS)
    Eliaz, R.
    Mengesha, B.
    Ovdat, T.
    Iakobishvili, Z.
    Hasdai, D.
    Kheifets, M.
    Klempfner, R.
    Beigel, R.
    Kalmanovich, E.
    Alcalai, R.
    Levi, A.
    EUROPEAN HEART JOURNAL, 2021, 42 : 1414 - 1414
  • [3] P2Y12 inhibitor monotherapy after coronary stenting according to type of P2Y12 inhibitor
    Kim, Juwon
    Jang, Woo Jin
    Lee, Wang Soo
    Choi, Ki Hong
    Lee, Joo Myung
    Park, Taek Kyu
    Yang, Jeong Hoon
    Choi, Jin-Ho
    Bin Song, Young
    Choi, Seung-Hyuk
    Gwon, Hyeon-Cheol
    Lee, Sang Hoon
    Oh, Ju-Hyeon
    Chun, Woo Jung
    Park, Yong Hwan
    Im, Eul-Soon
    Jeong, Jin-Ok
    Cho, Byung Ryul
    Oh, Seok Kyu
    Yun, Kyeong Ho
    Cho, Deok-Kyu
    Lee, Jong-Young
    Koh, Young-Youp
    Bae, Jang-Whan
    Choi, Jae Woong
    Yoon, Hyuck Jun
    Lee, Seung Uk
    Cho, Jang Hyun
    Choi, Woong Gil
    Rha, Seung-Woon
    Hahn, Joo-Yong
    HEART, 2021, 107 (13) : 1077 - 1083
  • [4] P2Y12 Inhibitor-Based Monotherapy
    Choudhary, Rahul
    Deora, Surender
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2020, 76 (10) : 1273 - 1274
  • [5] P2Y12 inhibitor monotherapy in patients undergoing percutaneous coronary intervention
    Capodanno, Davide
    Baber, Usman
    Bhatt, Deepak L.
    Collet, Jean-Philippe
    Dangas, George
    Franchi, Francesco
    Gibson, C. Michael
    Gwon, Hyeon-Cheol
    Kastrati, Adnan
    Kimura, Takeshi
    Lemos, Pedro A.
    Lopes, Renato D.
    Mehran, Roxana
    O'Donoghue, Michelle L.
    Rao, Sunil, V
    Rollini, Fabiana
    Serruys, Patrick W.
    Steg, Philippe G.
    Storey, Robert F.
    Valgimigli, Marco
    Vranckx, Pascal
    Watanabe, Hirotoshi
    Windecker, Stephan
    Angiolillo, Dominick J.
    NATURE REVIEWS CARDIOLOGY, 2022, 19 (12) : 829 - 844
  • [6] P2Y12 inhibitor monotherapy in patients undergoing percutaneous coronary intervention
    Davide Capodanno
    Usman Baber
    Deepak L. Bhatt
    Jean-Philippe Collet
    George Dangas
    Francesco Franchi
    C. Michael Gibson
    Hyeon-Cheol Gwon
    Adnan Kastrati
    Takeshi Kimura
    Pedro A. Lemos
    Renato D. Lopes
    Roxana Mehran
    Michelle L. O’Donoghue
    Sunil V. Rao
    Fabiana Rollini
    Patrick W. Serruys
    Philippe G. Steg
    Robert F. Storey
    Marco Valgimigli
    Pascal Vranckx
    Hirotoshi Watanabe
    Stephan Windecker
    Dominick J. Angiolillo
    Nature Reviews Cardiology, 2022, 19 : 829 - 844
  • [7] REPLY: P2Y12 Inhibitor-Based Monotherapy
    Angiolillo, Dominick J.
    Baber, Usman
    Dangas, George D.
    Mehran, Roxana
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2020, 76 (10) : 1274 - 1275
  • [8] Role of Monotherapy with a P2Y12 Inhibitor for Secondary Prevention in Patients with Established Atherosclerosis
    Juan J. Rodriguez
    Luis E. Baron
    Oscar C. Munoz
    Jonathan J. Diaz
    Current Cardiology Reports, 2022, 24 : 87 - 91
  • [9] Role of Monotherapy with a P2Y12 Inhibitor for Secondary Prevention in Patients with Established Atherosclerosis
    Rodriguez, Juan J.
    Baron, Luis E.
    Munoz, Oscar C.
    Diaz, Jonathan J.
    CURRENT CARDIOLOGY REPORTS, 2022, 24 (02) : 87 - 91
  • [10] P2Y12 Inhibitor Monotherapy after Percutaneous Coronary Intervention
    Zhou, Xuan
    Angiolillo, Dominick J.
    Ortega-Paz, Luis
    JOURNAL OF CARDIOVASCULAR DEVELOPMENT AND DISEASE, 2022, 9 (10)